NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jun 30 04:00PM ET
1.74
Dollar change
-0.11
Percentage change
-5.95
%
Index- P/E- EPS (ttm)-0.85 Insider Own- Shs Outstand5.73M Perf Week-5.16%
Market Cap10.18M Forward P/E- EPS next Y- Insider Trans- Shs Float3.25M Perf Month-4.92%
Enterprise Value5.45M PEG- EPS next Q- Inst Own0.10% Short Float0.75% Perf Quarter-3.33%
Income-4.85M P/S2.36 EPS this Y- Inst Trans0.39% Short Ratio0.78 Perf Half Y-12.78%
Sales4.32M P/B1.56 EPS next Y- ROA-45.93% Short Interest0.02M Perf YTD2.35%
Book/sh1.12 P/C2.13 EPS next 5Y- ROE-52.79% 52W High2.87 -39.37% Perf Year-19.07%
Cash/sh0.82 P/FCF- EPS past 3/5Y11.00% 2.81% ROIC-75.03% 52W Low1.50 16.00% Perf 3Y-36.50%
Dividend Est.- EV/EBITDA- Sales past 3/5Y209.15% 13.48% Gross Margin67.47% Volatility6.61% 7.06% Perf 5Y-49.71%
Dividend TTM- EV/Sales1.26 EPS Y/Y TTM-87.95% Oper. Margin-123.01% ATR (14)0.13 Perf 10Y-
Dividend Ex-Date- Quick Ratio5.92 Sales Y/Y TTM82.77% Profit Margin-112.26% RSI (14)45.15 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio6.80 EPS Q/Q-21.22% SMA20-1.93% Beta- Target Price5.00
Payout- Debt/Eq0.01 Sales Q/Q71.79% SMA50-3.12% Rel Volume3.66 Prev Close1.85
Employees- LT Debt/Eq0.01 EarningsFeb 28 AMC SMA200-12.20% Avg Volume31.30K Price1.74
IPOMar 02, 2017 Option/ShortNo / Yes EPS/Sales Surpr.- - Trades Volume114,532 Change-5.95%
May-30-25 06:00AM
Apr-10-25 06:00PM
Mar-05-25 06:00AM
Feb-18-25 07:00AM
Jan-17-25 06:00AM
06:00AM Loading…
Jan-15-25 06:00AM
Jan-14-25 06:00AM
Dec-06-24 09:17AM
08:35AM
Dec-03-24 03:45PM
08:35AM
Dec-02-24 06:00AM
Nov-21-24 06:33PM
Nov-18-24 08:30AM
Oct-30-24 07:00AM
07:00AM Loading…
Oct-29-24 07:00AM
Oct-16-24 06:00AM
Oct-15-24 06:00AM
Oct-04-24 06:30AM
Sep-25-24 07:00AM
Sep-24-24 07:00AM
Sep-05-24 11:54AM
Aug-21-24 07:00AM
Aug-20-24 07:00AM
Aug-16-24 06:00AM
Aug-15-24 06:14PM
Aug-07-24 06:00AM
Jul-17-24 07:00AM
Jul-15-24 08:00AM
Jul-02-24 06:00AM
07:00AM Loading…
Jun-12-24 07:00AM
Jun-11-24 07:00AM
Jun-05-24 06:00AM
May-31-24 06:00AM
06:00AM
May-08-24 07:50AM
May-07-24 07:00AM
06:00AM
May-03-24 06:00AM
Apr-15-24 06:00AM
Apr-10-24 06:00AM
Mar-07-24 06:00AM
Feb-21-24 06:00AM
Feb-13-24 06:00AM
Feb-08-24 06:00AM
Jan-16-24 06:00AM
Dec-22-23 06:00AM
Dec-04-23 06:00AM
Nov-28-23 06:33AM
Nov-13-23 06:00PM
Oct-30-23 07:21AM
Oct-18-23 06:00AM
Oct-11-23 06:00AM
Sep-18-23 07:30AM
Sep-14-23 01:30PM
Sep-13-23 06:00AM
Sep-11-23 06:00AM
Aug-23-23 08:30AM
Aug-14-23 06:00AM
Jul-26-23 02:45PM
Jul-25-23 06:00AM
Jul-24-23 06:00AM
Jul-19-23 08:30AM
Jul-11-23 06:00AM
Jul-05-23 06:00AM
Jun-30-23 06:00AM
Jun-22-23 06:00AM
May-30-23 06:00AM
May-16-23 07:30AM
May-08-23 01:11PM
06:00AM
May-02-23 06:00AM
Apr-19-23 06:00AM
Apr-11-23 06:00AM
Apr-06-23 06:00AM
Feb-15-23 06:00AM
Jan-25-23 06:00AM
Jan-18-23 05:00AM
Jan-17-23 07:10AM
Dec-23-22 06:00AM
Dec-05-22 06:00AM
Nov-16-22 07:00AM
Oct-26-22 06:00AM
Oct-13-22 10:28AM
06:00AM
Oct-04-22 06:00AM
Aug-29-22 07:00AM
Aug-19-22 07:23AM
06:00AM
Jul-26-22 07:07AM
06:00AM
Jul-11-22 06:00AM
Jul-07-22 06:00AM
May-11-22 06:00AM
May-09-22 06:00AM
May-05-22 08:22PM
Apr-27-22 06:00AM
Apr-19-22 07:33AM
Mar-25-22 05:21AM
Mar-16-22 09:30AM
Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. Its proprietary technology is based on polyclonal immunoglobulins derived from engineered hyper-immune bovine colostrum. This technology can be used to target viruses or bacteria and neutralize the toxins they produce on mucosal surfaces. It operates through the Research and Development, and Hyperimmune Products segments. The Research and Development segment includes projects performed in Australia and United States. The Hyperimmune Products segment is composed of Travelan, and Protectyn activities which occur in Australia, United States, and rest of the world. The company was founded on January 13, 1994, and is headquartered in Carlton, Australia.